Consequences of chromsome18q deletions
- PMID: 26235940
- DOI: 10.1002/ajmg.c.31446
Consequences of chromsome18q deletions
Abstract
Providing clinically relevant prognoses and treatment information for people with a chromsome18q deletion is particularly challenging because every unrelated person has a unique region of hemizygosity. The hemizygous region can involve almost any region of 18q including between 1 and 101 genes (30 Mb of DNA). Most individuals have terminal deletions, but in our cohort of over 350 individuals 23% have interstitial deletions. Because of this heterogeneity, we take a gene by gene approach to understanding the clinical consequences. There are 196 genes on 18q. We classified 133 of them as dosage insensitive, 15 (8%) as dosage sensitive leading to haploinsufficiency while another 10 (5%) have effects that are conditionally haploinsufficient and are dependent on another factor, genetic or environmental in order to cause an abnormal phenotype. Thirty-seven genes (19%) have insufficient information to classify their dosage effect. Phenotypes attributed to single genes include: congenital heart disease, minor bone morphology changes, central nervous system dysmyelination, expressive speech delay, vesicouretreral reflux, polyposis, Pitt-Hopkins syndrome, intellectual disability, executive function impairment, male infertility, aural atresia, and high frequency sensorineural hearing loss. Additionally, identified critical regions for other phenotypes include: adolescent idiopathic scoliosis and pectus excavatum, Virchow-Robin perivascular spaces, small corpus callosum, strabismus, atopic disorders, mood disorder, IgA deficiency, nystagmus, congenital heart disease, kidney malformation, vertical talus, CNS dysmyelination growth hormone deficiency and cleft palate. Together these findings make it increasingly feasible to compile an individualized syndrome description based on each person's individuated genotype. Future work will focus on understanding molecular mechanisms leading to treatment.
Keywords: 18q deletion; 18q-; chromosome 18; gene dosage; haploinsufficiency; hemizygosity.
© 2015 Wiley Periodicals, Inc.
Similar articles
-
Establishing a reference group for distal 18q-: clinical description and molecular basis.Hum Genet. 2014 Feb;133(2):199-209. doi: 10.1007/s00439-013-1364-6. Epub 2013 Oct 5. Hum Genet. 2014. PMID: 24092497 Free PMC article.
-
Interstitial deletion of 18q: comparative genomic hybridization array analysis of 46, XX,del(18)(q21.2.q21.33).Birth Defects Res A Clin Mol Teratol. 2010 Feb;88(2):132-5. doi: 10.1002/bdra.20633. Birth Defects Res A Clin Mol Teratol. 2010. PMID: 19813260
-
The 18q deletion syndrome and analysis of the critical region for orofacial cleft at 18q22.3.J Craniomaxillofac Surg. 2009 Jul;37(5):272-5. doi: 10.1016/j.jcms.2008.12.002. Epub 2009 Jan 20. J Craniomaxillofac Surg. 2009. PMID: 19157891
-
Identification of 2.3-Mb gene locus for congenital aural atresia in 18q22.3 deletion: a case report analyzed by comparative genomic hybridization.Otol Neurotol. 2006 Apr;27(3):427-32. doi: 10.1097/00129492-200604000-00022. Otol Neurotol. 2006. PMID: 16639285 Review.
-
8.6Mb interstitial deletion of chromosome 4q13.3q21.23 in a boy with cognitive impairment, short stature, hearing loss, skeletal abnormalities and facial dysmorphism.Genet Couns. 2011;22(4):353-63. Genet Couns. 2011. PMID: 22303795 Review.
Cited by
-
Cytogenomic characterization of small supernumerary marker chromosomes in patients with pigmentary mosaicism.Front Genet. 2024 Apr 16;15:1356786. doi: 10.3389/fgene.2024.1356786. eCollection 2024. Front Genet. 2024. PMID: 38711916 Free PMC article.
-
The role of copy number variants in the genetic architecture of common familial epilepsies.Epilepsia. 2024 Mar;65(3):792-804. doi: 10.1111/epi.17860. Epub 2024 Jan 20. Epilepsia. 2024. PMID: 38101940
-
18q21.1q21.32 Deletion in a Patient With Juvenile Cerebral Infarction.Cureus. 2023 Jul 27;15(7):e42534. doi: 10.7759/cureus.42534. eCollection 2023 Jul. Cureus. 2023. PMID: 37521594 Free PMC article.
-
In skeletal muscle and neural crest cells, SMCHD1 regulates biological pathways relevant for Bosma syndrome and facioscapulohumeral dystrophy phenotype.Nucleic Acids Res. 2023 Aug 11;51(14):7269-7287. doi: 10.1093/nar/gkad523. Nucleic Acids Res. 2023. PMID: 37334829 Free PMC article.
-
Full etiologic spectrum of pediatric severe to profound hearing loss of consecutive 119 cases.Sci Rep. 2022 Jul 19;12(1):12335. doi: 10.1038/s41598-022-16421-x. Sci Rep. 2022. PMID: 35853923 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous